ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,510Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 252

$1.32M Total Retail Price of All Prescriptions

Rank: 5 out of 252

805 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 805 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 805 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,912 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 778 696 1 1
HYDROCODONE-ACETAMINOPHEN 729 358 S3 2 5
OMEPRAZOLE 718 569 3 6
FUROSEMIDE 621 525 4 7
LISINOPRIL 594 486 5 3
GABAPENTIN 583 422 6 11
SIMVASTATIN 511 401 7 2
WARFARIN SODIUM 485 436 8 14
AMLODIPINE BESYLATE 425 348 9 4
CITALOPRAM HBR 417 318 10 15
METFORMIN HCL 398 262 11 9
POTASSIUM CHLORIDE 375 329 12 8
PRAVASTATIN SODIUM 328 254 13 12
CARVEDILOL 324 289 14 22
METOPROLOL TARTRATE 322 263 15 10
DONEPEZIL HCL 284 262 16 28
FAMOTIDINE 260 241 17 59
ATENOLOL 256 172 18 18
OXYCODONE HCL 238 55 S2 19 89
HYDROCHLOROTHIAZIDE 224 193 20 13
TAMSULOSIN HCL 212 165 21 26
TRAZODONE HCL 207 166 22 31
MIRTAZAPINE 198 190 23 58
ZOLPIDEM TARTRATE 190 106 24 21
NAMENDA 190 171 24 41
MELOXICAM 186 133 26 20
CYMBALTA 179 114 27 45
ALLOPURINOL 165 124 28 30
SERTRALINE HCL 163 133 29 27
LOSARTAN POTASSIUM 161 152 30 24
AMITRIPTYLINE HCL 153 70 R 31 46
CLOPIDOGREL 150 121 32 29
QUETIAPINE FUMARATE 144 93 33 77
CIPROFLOXACIN HCL 142 127 34 61
FLUOXETINE HCL 141 66 35 57
ISOSORBIDE MONONITRATE ER 138 129 36 50
CYCLOBENZAPRINE HCL 130 52 R 37 51
TRAMADOL HCL 130 119 37 17
METOPROLOL SUCCINATE 129 124 39 19
ESCITALOPRAM OXALATE 128 74 40 56
PREDNISONE 127 101 41 42
CLONIDINE HCL 125 93 42 35
NOVOLOG 124 99 43 106
GLIMEPIRIDE 121 74 44 40
METHADONE HCL 116 33 S2 45 161
TOPIRAMATE 115 53 46 151
ATORVASTATIN CALCIUM 113 100 47 16
DIOVAN 113 88 47 38
JANUVIA 111 88 49 88
KLOR-CON M20 110 96 50 69
SPIRONOLACTONE 109 89 51 53
NEXIUM 106 66 52 23
LYRICA 105 47 53 66
LANTUS 105 85 53 55
DIGOXIN 104 102 55 44
METOCLOPRAMIDE HCL 101 70 56 110
PANTOPRAZOLE SODIUM 100 72 57 62
AZITHROMYCIN 98 64 58 37
FLUTICASONE PROPIONATE 97 66 59 36
PLAVIX 95 84 60 43
COMBIVENT 95 77 60 123
TESTOSTERONE CYPIONATE 93 63 S3 62 295
RANITIDINE HCL 91 59 63 48
SPIRIVA 89 57 64 68
LOVASTATIN 85 69 65 39
RISPERIDONE 83 83 66 81
ADVAIR DISKUS 83 63 66 63
GLIPIZIDE 79 61 68 52
TRIAMTERENE-HCTZ 79 66 68 33
CEPHALEXIN 77 58 70 121
DETROL LA 75 31 71 178
LEVOFLOXACIN 75 66 71 79
IPRATROPIUM-ALBUTEROL 74 68 73 155
HYDRALAZINE HCL 72 69 74 95
ABILIFY 72 35 74 185
VENLAFAXINE HCL 72 51 74 160
FENTANYL 69 61 S2 77 126
PROPRANOLOL HCL 68 68 78 111
LANTUS SOLOSTAR 67 43 79 109
CARBIDOPA-LEVODOPA 65 59 80 107
POLYETHYLENE GLYCOL 3350 64 60 81 67
MEGESTROL ACETATE 64 52 R 81 138
ALENDRONATE SODIUM 64 60 81 32
BUPROPION XL 64 50 81 188
OXCARBAZEPINE 64 25 81 204
METHYLPREDNISOLONE 63 36 86 118
BENAZEPRIL HCL 63 56 86 80
SEROQUEL 62 39 88 149
ALBUTEROL SULFATE 60 58 89 170
HUMALOG 60 48 89 226
PROMETHAZINE HCL 60 28 R 89 85
ROPINIROLE HCL 59 36 92 84
DILTIAZEM 24HR CD 59 44 92 104
SYMBICORT 58 44 94 137
PAROXETINE HCL 58 43 94 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 53 96 87
ENALAPRIL MALEATE 56 47 96 72
OXYCODONE HCL-ACETAMINOPHEN 55 30 S2 98 175
OXYBUTYNIN CHLORIDE 55 26 98 123
IBUPROFEN 55 51 98 130
CHLORTHALIDONE 54 32 101 141
TERAZOSIN HCL 54 35 101 94
HYDROMORPHONE HCL 53 20 S2 103 272
BUSPIRONE HCL 53 41 103 119
LIDODERM 53 47 103 248
DIVALPROEX SODIUM 51 31 106 113
LOSARTAN-HYDROCHLOROTHIAZIDE 51 50 106 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 19 106 25
AGGRENOX 51 51 106 168
SUCRALFATE 51 40 106 125
DOXAZOSIN MESYLATE 50 45 111 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.